MedPath
NMPA Approval

Brimonidine Tartrate Eye Drops

国药准字HJ20160426

October 29, 2024

H20160426

Drug Information

酒石酸溴莫尼定滴眼液

眼用制剂

0.15%(5ml:7.5mg)

化学药品

October 29, 2024

October 28, 2029

Company Information

Applicant Company

艾伯维公司

1 N Waukegan Rd, North Chicago, IL 60064 United States of America

Manufacturing Company

8301 Mars Drive, Waco, TX 76712 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酒石酸溴莫尼定滴眼液 - NMPA 批准文号 | MedPath